Inspire Medical's (INSP) Inspire Therapy Gets CE Mark Approval
The latest regulatory achievement is a significant milestone for Inspire Medical, which is expected to solidify its foothold in the global obstructive sleep apnea treatment space.
Is This The Right Entry Point To Add Inspire Medical Systems (INSP)?
Express News | Inspire Medical Systems, Inc. Announces the Appointment of Melissa J. Mann as Chief People Officer
Inspire Medical Systems' Implantable Inspire IV Gains EU Approval for Full-Body MRI Compatibility
Inspire Medical Systems (INSP) said Friday the European Union has approved CE marketing certification for patients with the implanted Inspire IV neurostimulator device, allowing full-body magenetic
Express News | Inspire Medical Systems, Inc. Announces Ce Mark Certification Under the European Union’s Medical Device Regulation for Inspire Therapy
Med-tech and Healthcare Stocks With Upside During 2Q Earnings - Baird
Should You Investigate Inspire Medical Systems, Inc. (NYSE:INSP) At US$146?
Inspire Medical Systems, Inc. (NYSE:INSP), might not be a large cap stock, but it saw a decent share price growth of 11% on the NYSE over the last few months. While good news for shareholders,
Express News | Inspire Medical Systems Inc : Leerink Partners Cuts Target Price to $156 From $203
Deep Dive Into Inspire Medical Systems Stock: Analyst Perspectives (6 Ratings)
Ratings for Inspire Medical Systems (NYSE:INSP) were provided by 6 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.The table below offers a condensed view of
Inspire Medical Systems Price Target Cut to $217.00/Share From $280.00 by Truist Securities
Inspire Medical Systems Price Target Cut to $217.00/Share From $280.00 by Truist
Truist Financial Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Announces Target Price $217
Truist Financial analyst Richard Newitter maintains $Inspire Medical Systems(INSP.US)$ with a buy rating, and sets the target price at $217.According to TipRanks data, the analyst has a success rate
Express News | Inspire Medical Systems Inc : Truist Securities Cuts Target Price to $217 From $280
Truist Cuts Price Target on Inspire Medical Systems to $217 From $280, Maintains Buy Rating
Inspire Medical Systems (INSP) has an average investment rating of outperform among analysts polled by Capital IQ, with price targets ranging from $170 to $280.
Inspire Medical Systems Is Maintained at Overweight by Morgan Stanley
Inspire Medical Systems Is Maintained at Overweight by Morgan
Inspire Medical Systems Price Target Cut to $210.00/Share From $250.00 by Morgan Stanley
Inspire Medical Systems Price Target Cut to $210.00/Share From $250.00 by Morgan
Inspire Medical Systems Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/15/2024 53.17% Morgan Stanley $250 → $210 Maintains Overweight 06/24/2024 24% Stifel $210 → $170
Morgan Stanley Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Cuts Target Price to $210
Morgan Stanley analyst Kallum Titchmarsh maintains $Inspire Medical Systems(INSP.US)$ with a buy rating, and adjusts the target price from $250 to $210.According to TipRanks data, the analyst has a
Morgan Stanley Cuts Price Target on Inspire Medical Systems to $210 From $250, Keeps Overweight Rating
Inspire Medical Systems (INSP) has an average investment rating of outperform among analysts polled by Capital IQ, with price targets ranging from $170 to $280.
Express News | Inspire Medical Systems Inc : Mizuho Cuts Target Price to $200 From $250
Inspire Medical (INSP) Gave Back Its Gains in Q2